Courage Therapeutics
PrivateLast Round
Seed
Nov 3, 2025
Total Funding Raised
$19.04M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Courage Therapeutics is a biotechnology company that develops small molecule and peptide therapeutics targeting melanocortin receptors to treat obesity and restrictive eating disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Courage Therapeutics Comparables
Compare Courage Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kalohexis | 86% | |
| Gazella Biotech | 72% | |
| Palatin Technologies | 71% | |
Courage Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 3, 2025 | ||||
| Seed | May 16, 2025 | ||||
| Grant | Apr 22, 2021 | ||||
| Seed | Mar 24, 2021 |
Courage Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
| NIH RADx | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Arsenal Bridge Ventures | Seed |
| MIT Alumni Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2025
$10M round led by Arsenal Bridge Ventures
- May 16, 2025
$7.8M round completed.
Courage Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Courage Therapeutics's valuation, stock price, and market status.